C4 Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

C4 Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $35.95 million for the year ending 2025.

  • C4 Therapeutics, Inc. showed an increase of +1.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from C4 Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), C4 Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 21.5%.
  • Historical annual values: Fiscal year 2025: $35.95 million | Fiscal year 2024: $35.58 million | Fiscal year 2023: $20.76 million | Fiscal year 2022: $31.10 million | Fiscal year 2021: $45.79 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: